Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy

Abstract Background Recombinant thrombomodulin (rTM) is a promising anticoagulant. Improvements in disseminated intravascular coagulation (DIC) and the amelioration of bleeding complications in DIC patients were reported to be greater with rTM therapy than with unfractionated heparin therapy. Howeve...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thrombosis research 2015-07, Vol.136 (1), p.20-23
Hauptverfasser:	Takezako, Naoki, Sekiguchi, Naohiro, Nagata, Akihisa, Homma, Chiho, Takezako, Yayoi, Noto, Satoshi, Natori, Kazuhiko, Miwa, Akiyoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	acute myeloid leukemia Cell Adhesion Molecules - blood Cytokines - blood DIC Hematology, Oncology and Palliative Medicine Humans Inflammation Mediators - blood Matrix Metalloproteinases - blood outcome recombinant thrombomodulin Venous Thrombosis - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!